Varian

Varian, Inc. is a prominent global supplier of scientific instruments and vacuum technologies, primarily catering to life science and industrial applications. The company offers a comprehensive range of products and services, including instruments, vacuum products, laboratory consumable supplies, software, and training, supported by an extensive global distribution network. Varian employs approximately 3,900 individuals and maintains manufacturing facilities across North America, Europe, and Asia Pacific. Through its diverse offerings, Varian plays a critical role in advancing research and development in various scientific fields.

Nikita Kulkarni

Director, Corporate Development

4 past transactions

Berkeley Lights

Series E in 2018
Berkeley Lights, Inc. is a digital cell biology company based in Emeryville, California, established in 2011. The company specializes in the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights offers an integrated platform that includes proprietary consumables such as OptoSelect chips and reagent kits, along with automation systems and application software. Utilizing innovative micro-droplet technology, the company transforms biological processes, enabling researchers to study cell interactions more effectively. This platform supports various applications, including biotherapeutic discovery and development, cellular therapy manufacturing, and synthetic biology, addressing the growing demands in these fields.

Epic Sciences

Series E in 2018
Epic Sciences, Inc. is a diagnostics company based in San Diego, California, focused on improving cancer management through the development of highly sensitive tests that identify and characterize circulating tumor cells (CTCs) using minimally invasive blood samples. Founded in 2008, the company’s platform enables the profiling of single-cell phenotypes and genotypes, providing detailed information on biomarker expression levels, morphologic characteristics, and genetic changes. Epic Sciences offers the Oncotype DX AR-V7 Nucleus Detect test specifically for patients with metastatic castration-resistant prostate cancer, as well as biopharma solutions. The company collaborates with biotechnology and pharmaceutical firms, major cancer centers, and renowned research institutions, including the National Cancer Institute and the National Institutes of Health, to enhance personalized medicine and guide treatment decisions.

Analogix

Acquisition in 2007
Creates, sells, and supports phramaceutical chromatography systems and consumables

LipoScience

Series F in 2006
LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.